SPHDF Projected Dividend Yield
Santhera Pharmaceuticals Holdings Ltd ( OTCBB : SPHDF )Santhera Pharmaceutical is a holding company. Through its subsidiaries, Co. is a specialty pharmaceutical company, focuses on the discovery, development, and marketing of pharmaceutical products for the treatment of orphan neuromuscular diseases. Its compound, Catena, is used for the symptomatic treatment of Friedreich's Ataxia. Co.'s programs also include Fipamezole for the treatment of Dyskinesia in Parkinson's disease; omigapil, a molecule that is in preparation for a Phase II/III clinical development program in congenital muscular dystrophy; and Melanocortin-4 Receptor Antagonists, which is in preclinical stage for the treatment of Cancer Cachexia. 20 YEAR PERFORMANCE RESULTS |
SPHDF Dividend History Detail SPHDF Dividend News SPHDF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |